A tablet-based set of video games called SmartMe&You reflected cognitive status in people with Parkinson’s-related mild cognitive impairment or mild-to-moderate dementia, a new study found. “These video games have the potential to serve as a reliable, unsupervised digital home telemonitoring cognitive battery for periodic assessment of cognitive status in…
News
Blood levels of certain protein markers previously linked to Alzheimer’s disease may help predict dementia risk in people with Parkinson’s disease, according to a new study. Although the findings need to be confirmed in larger studies, the results suggest that these two markers, pTau217 and pTau231, may eventually help…
Once-daily treatment with tavapadon, an experimental oral small molecule being developed by Abbvie, outperformed a placebo at easing motor symptoms and problems with daily functioning in people with early Parkinson’s disease, while somnolence, or excessive sleepiness, and impulse control disorders occurred infrequently. These are six-month data from…
Specialists evaluating cognitive impairment in people with Parkinson’s disease rely on much more than the score from a commonly used cognitive screening test. They also look for patterns in how patients performed on the test alongside their medical history and other health-related information, according to a new U.S. study.
People with Parkinson’s disease who participated in a U.K. study said maintaining their oral health helped preserve their independence and well-being, although they faced challenges performing mouth care at home. Interviews with patients and care partners showed that Parkinson’s symptoms, including impaired hand control, fatigue, and balance issues,…
Older people with Parkinson’s disease who engage in regular exercise tend to perform worse on measures of physical fitness than similarly aged adults without the disease, but these differences are not explained by variations in body muscle mass, a study showed. While men and women with Parkinson’s tend to…
Georgia has expanded its medical cannabis program, allowing registered patients ages 21 and older to access medical cannabis flower and vaporization products for the first time and removing the previous requirement that certain diseases, including Parkinson’s disease, be advanced or end-stage. The change comes under the Putting Georgia’s…
Mighty Therapeutics, a Massachusetts-based biotech company, announced that it has raised $150 million to support the clinical development of its treatment candidates for Parkinson’s disease and other neurodegenerative conditions. The new funding is expected to expedite pipeline initiatives in Parkinson’s as well as ongoing late-stage drug development programs…
A newly developed yoga program designed specifically to improve mobility and mental well-being for people in the early stages of Parkinson’s disease is heading to a clinical trial. Developed by a trio of scientists, the customized program was recently detailed in the journal Annals of Neurosciences, under the article…
An investigational stem cell-based therapy that would replace the nerve cells, or neurons, lost due to Parkinson’s disease was found to be generally safe and feasible for use after one year of study in a first-in-human clinical trial — results the researchers say support the treatment’s continued clinical development.
Recent Posts
- Tablet games may help assess thinking and memory problems in Parkinson’s
- Pondering the importance of routines for my dad, who has Parkinson’s
- Blood markers may help predict dementia risk in Parkinson’s disease
- How a sporting goods employee made my uncle feel seen
- Once-daily therapy eases early Parkinson’s symptoms in Phase 3 trial